Monosopt Eye Drops (Dorzolamide Hydrochloride )

• Composition :
  Dorzolamide 2% Eye Drops
• Indications :
  Indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
• Pharmacodynamics :
  : Dorzolamide hydrochloride inhibits carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport
• Dosage and administration :
  : The recommended dosage is one drop in the affected eye(s) three times daily.
• Contraindications :
  Hypersensitivity to the active substance(s) or to any of the excipients
• Precautions and warnings :
  Caution should be used when prescribing Monosopt eye drops in patients with Bacterial Keratitis, Low Corneal Endothelial cell count, allergic reactions
• Use in pregnancy, lactation & pediatrics :
  There are no adequate and well-controlled studies in pregnant women, nursing woman. Safety and effectiveness in pediatric population have not been established
• Drug interactions :
  No drug interaction has been documented for Dorzolamide
• Adverse reactions :
  The most frequently reported adverse events are ocular burning, stinging, or discomfort, Superficial punctate keratitis, ocular allergic reaction, blurred vision, eye redness, tearing, dryness, and photophobia, headache, nausea, asthenia/fatigue; and, rarely, skin rashes and iridocyclitis, allergic reaction following ocular administration.
• Therapy Area :
  Opthalmologicals